Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-08

Steven W. Barger

Federal Grant PI High Impact

Professor

Also affiliated: United States Department of Veterans Affairs (2003–2006); University of Kentucky (1993–1996); University of Colorado Boulder (1998); Vanderbilt University (1989–1992); Veterans Health Administration (1998–2003); Central Arkansas Veterans Healthcare System (1998–2026); Geriatric Research Education and Clinical Center (1998–2000); National Institute on Aging (1996); John L. McClellan Memorial Veterans Hospital (1997–2016); University of Toledo (2014)

49 h-index 138 pubs 10,207 cited

  • Animals
  • Humans
  • Cells, Cultured
  • Rats
  • Neurons
  • Alzheimer Disease
  • Mice
  • Rats, Sprague-Dawley
  • Glutamic Acid
  • Calcium
  • Amyloid beta-Protein Precursor
  • Microglia
  • Brain
  • NF-kappa B
  • Male

Biography and Research Information

OverviewAI-generated summary

Steven W. Barger, a professor at the University of Arkansas for Medical Sciences, has focused his research on the cellular and molecular mechanisms underlying neurological disorders, particularly Alzheimer's disease. His work investigates the role of various factors, including amyloid precursor protein metabolites, glucose transport, and inflammatory mediators, in neuronal dysfunction and death. Barger has received significant federal funding from the NIH/National Institute on Aging for two grants totaling over $750,000. These grants support his investigations into the role of glucose transport in Alzheimer's pathogenesis and the compromised function of glial glucose transporters in aging and the disease.

His research has explored the protective effects of tumor necrosis factors against amyloid beta-peptide toxicity and the involvement of specific signaling pathways, such as p38-MAPK, in mediating the pathological effects of microglia on neurons. Barger's publications also address the influence of beta-amyloid precursor protein metabolites on neuronal calcium homeostasis and the modulation of neuronal activity by secreted beta-amyloid-precursor protein. He has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Joseph Asante, Robert J. Shmookler Reis, W. Sue T. Griffin, and Srinivas Ayyadevara.

With an h-index of 50 and over 10,000 citations across 139 publications, Barger is recognized as a highly cited researcher. His work contributes to the broader understanding of neurodegenerative diseases and potential therapeutic targets.

Metrics

  • h-index: 49
  • Publications: 138
  • Citations: 10,207

Positions

  • Research Health Scientist 1996–present
    Central Arkansas Veterans Healthcare System Geriatric Research, Education & Clinical Center ORCID
  • Professor 1995–present
    University of Arkansas for Medical Sciences Geriatrics; Neuroscience Institutional directory

Selected Publications

  • Insulin Growth Factor 1 affects glutamate receptor activity differently in primary cultures of neocortical versus hippocampal neurons (2026)
    bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
  • Impact of P-glycoprotein substrates on transendothelial transport of amyloid-β peptide in an in vitro model (2026)
    Neuroscience DOI OpenAlex
  • Modulation of apolipoprotein E receptor-2 by ApoE4, amyloid β-peptide, reelin, and secreted amyloid precursor protein: a common point of impact in Alzheimer’s disease pathogenesis (2026)
    Frontiers in Molecular Neuroscience DOI OpenAlex
  • Microglial serine racemase knockout alleviates Alzheimer-like neuropathology and behavioral deficit via lactylation-mediated anti-inflammation (2026)
    Communications Biology DOI OpenAlex
  • Impact of P-Glycoprotein Substrates on Transendothelial Transport of Amyloid-β Peptide (2025)
    SSRN Electronic Journal DOI OpenAlex
  • Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study (2025)
    Journal of Alzheimer s Disease 2 citations DOI OpenAlex
  • P-glycoprotein and Alzheimer’s Disease: Threats and Opportunities (2025)
    ASN NEURO 7 citations DOI OpenAlex
  • Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules (2024)
    Communications Biology 21 citations DOI OpenAlex
  • Design, synthesis, and characterization of novel system xC− transport inhibitors: inhibition of microglial glutamate release and neurotoxicity (2023)
    Journal of Neuroinflammation 7 citations DOI OpenAlex
  • Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan (2023)
    Pharmaceuticals 14 citations DOI OpenAlex
  • Central repeat fragment of reelin leads to active reelin intracellular signaling and rescues cognitive deficits in a mouse model of reelin deficiency (2023)
    Cellular Signalling 6 citations DOI OpenAlex
  • Design, synthesis, and characterization of novel Xc- transport inhibitors: Inhibition of microglial glutamate release and neurotoxicity (2023)
    Research Square 1 citation DOI OpenAlex
  • Amyloid β-Peptide Effects on Glucose Regulation Are Dependent on Apolipoprotein E Genotype (2023)
    eNeuro 2 citations DOI OpenAlex
  • Liraglutide Counteracts Endoplasmic Reticulum Stress in Palmitate-Treated Hypothalamic Neurons without Restoring Mitochondrial Homeostasis (2022)
    International Journal of Molecular Sciences 6 citations DOI OpenAlex
  • Glucose transport in the regulation of T-cell activation: the journey may be as important as the destination (2022)
    Immunometabolism DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 2 $754,900 total

NIH Contact PI Apr 2023 - Mar 2028

Role of glucose transport in Alzheimer's disease pathogenesis

National Institute on Aging $382,500 R01
NIH Contact PI Apr 2021 - Dec 2026

Compromised function of a glial glucose transporter in aging and Alzheimer's disease

National Institute on Aging $372,400 R01

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • Molecular aspects of endocrine and metabolic dysregulation in neurodegeneration NIH/NIA
  • Neuroscience Research Center Core Facility at UAMS NIH
  • Secreted Alzheimer amyloid precursor protein (sAPP) antagonizes Reelin receptors NIH
  • CYCLIC GMP AND KB-DEPENDENT TRANSCRIPTION IN NEURONS NIH
  • TO ESTABLISH UAMS ACCOUNT FOR SALARY SUPPORT OF XIANRONG MAO. INVOICE U OF A FOUNDATION OFFICE University of Arkansas Foundation
  • Destablization of LRP family receptors by Alzheimer-related presenilin mutations NIH
  • PPG Core C: Molecular Analysis NIH/NIA
  • Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases - Continuation - Continuation NIH/Nat. Inst. on Aging

Collaboration Network

194 Collaborators 60 Institutions 10 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics